Science and Medicine Group has named Tony LePage as Chief Executive Officer, bringing more than 20 years of healthcare market research leadership to the role. Alongside the appointment, SMG promoted Dameka Williams to Chief Research…

Multiomics has moved from buzzword to budget line — and instrument vendors are taking notice. From new mass spec platforms at ASMS 2026 to sequencing chemistries at AGBT, the race is on to own the…

Guest Contributor Karthik Achari, founder of PepMD, explores why traditional provider verification processes are struggling to keep pace with the rapid expansion of telehealth and decentralized care models. Today’s patients will probably check online ratings…

As regulators accelerate the phase-out of animal testing, New Approach Methodologies are moving from policy to practice — and reshaping which neuroscience instruments, readouts, and workflows matter most.

SDi analysts cover the key findings from the 2026 Global Assessment Report — market sizing, five-year forecasts, vendor rankings, and competitive trends across 80+ instrument technologies. Free. On demand. 30 minutes.